Manuscript Submission

All submitted manuscripts should contain original research not previously published and not under consideration for publication elsewhere. CJCB welcomes original and novelty research articles on tumor gene therapy, vaccine, antibody treatment, small molecule targeted therapy, and immune cell and cytokine treatment, etc. Short communications, reviews and case reports are also accepted and will undergo the same peer-review and editorial process as original research papers. The format of manuscripts should abide in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals"（ICMJE）.

Authors are required to submit manuscripts electronically at http://www.biother.org, or be e-mailed to cjcb@biother.org as an attachment, or be postal mailed (2 hard copies plus a disk is required, preferably in Word).Upon the receipt of the manuscript, the CJCB Editorial Office will assign a code number to it within 5 d, which is to be used to stand for it in all subsequent correspondence.

CJCB has a special channel for fast publication of innovative articles (please provide Novelty Assessment Report), they may be published within 2 months in “prompt report”. Articles sponsored by National Foundations or National Key Programs enjoy the priority of being accepted and published.

Conflicts of interest

     Each submitted manuscript should has 1) a statement that the manuscript has not been published in part or whole or under consideration for publication elsewhere in any language, 2) a statement that all authors have agreed to be so listed and have seen and approved the manuscript and its submission to CJCB, 3) a list of the specific contributions of each author to the work (conception and design, or acquisition of data, or analysis.

Ethics

Work on human beings that is submitted to CJCB should in accordance with international ethical standards such as the Declaration of Helsinki, and the research protocol must be approved by an Institutional Review Board (IRB) or equivalent human ethics committee. Authors are required to state clearly in the text that all persons gave their informed consent. The confidentiality of patients' information must be preserved, and a statement to that effect must be included. Laboratory research involving animals must comply with National Research Council’s guidelines, the experimental protocol must be approved by the institutional animal care and use committee (IACUC).

     When a clinical trial is submitted, we require the authors register their study in Chinese Clinical Trial Registration and Publish Collaboration (ChiCTRPC) and attach the registration number on the manuscript submitted. For reports of randomized controlled trials, authors should refer to the CONSORT statement, which can be found at www.consort-statement.org.

Peer-Review Policy

Only manuscripts of high relevance and suitability will enter into the peer-review process, which will be conducted by at least 2 experts in the related field. Authors may suggest that specific individuals be or not be involved as reviewers. A statistician will be consulted for comment when an article involves too much statistics. After peer reviewing, a final decision of acceptance, or requires revision before publication, or rejection will be made by the Editorial Board meeting based on the reviewers’ comments within 45 days.

Revision

If revision is required, the authors should amend and resubmit the manuscript within 20 days. Resubmission after 20 days may be considered a new submission. If the revision is not satisfactory to the reviewers, the author may be asked to make a second revision.

Proofreading

Checking the proofs is solely the authors' responsibility. The publisher is not responsible for any errors not marked by the author on the proof. The proof must be returned to the Editorial Office within 7 days after its receipt.

Copyright Assignment

Upon acceptance of an article, authors will be asked to sign copyright agreement form and transfer copyright to the Chinese Immunology Association and Chinese Anti-cancer Association. The corresponding author is responsible for obtaining signatures of coauthors and prove that the final version has been seen and approved by all authors. Upon acceptance of your paper, please fax the copyright agreement form to the Editorial Office of CJCB within 7 days.

Costs

A nonrefundable submission fee of 100 RMB for each manuscript must be paid regardless of the decision on the paper. A charge of 250 RMB per printed page will be levied on all accepted manuscripts. The cost for color photographs is 800 RMB per page. The corresponding author, at no cost, will be provided with two issues and 10 print copies.

Preparation of manuscripts

Manuscripts should include an abstract and appropriate experimental details to support the conclusions. Manuscripts should include the following sections, title, abstract and keywords, text (introduction, methods, results, and discussion), references. If acronyms or abbreviations are used, the name/term should be first indicated in full followed by the short form/acronym. A full name is not required for the most common biochemical abbreviations (e.g. ATP).

Title

The title should be as short and informative as possible (less than 20 Chinese words). All nonfunctional words should be deleted, such as ‘the’, ‘studies on’, ‘observations of’, and ‘roles of’, etc.

Author and affiliation

Authors should have participated sufficiently in the work to take public responsibility for the content. Capitalize all the letters in the surname, spell out the given name in full, and include a hyphen between the syllables of Chinese names. The affiliation is the institute or laboratory where the work was done. Footnotes may include 1) sources of financial support, 2) the brief introduction of first author, and 3) the corresponding author (name, full postal mailing address, and e-mail address).

Abstract

Short Communicating and Case Reports do not need English abstracts, and should include Chinese abstracts. Prompt report, original research article and review should have both Chinese and English abstracts of no more than 400 words. The abstract should be in structured form, under the following headings: Objective (the purpose of this study), Methods, Results(major findings), and Conclusion (in a definite, conclusive, and short statement). Abstracts for commentary, academician forum, expert forum, and review articles should be in unstructured form. And the abstract must be informative rather than indicative, Emphasizing the new and important aspects of the review.

Key Words

Authors should provide 3 to 10 key words that capture the main topics of the article. Terms from Medical Subject Headings (MeSH) list of Index Medicus should be used.

Text

The text is usually divided into sections with headings such as Introduction, Materials and Methods, Results, and Discussion (IMRAD format). A Use of standard abbreviations and SI units of measurement (according to the Systeme International d’Unites) is encouraged. Abbreviations, if used, should be defined on their first appearance in the text.

Introduction

Introduction should give a short (no more than 300 words), clear account of the background and reasons and the purposes of the study and their relationship to earlier work in the field. It should not be a review of the literature.

Materials and Methods

       This section should contain sufficient detail so that the experiments reported can be repeated by a qualified reader. Novel experimental procedures should be described in detail, but published procedures can be referred to by literature citation of the original article and published modifications. Statistical methods should be described when they are used to verify the results. Statistical terms, abbreviations, and symbols must be defined, and computer software must be specified. For reports of randomized controlled trials authors should refer to the CONSORT statement. Descriptions about randomness, controlling, and blindness in experimental design should be included.

Results

Data included should be original, fully labeled, and essential to the report. Text should be presented with concise, accurate subheadings. Illustrations such as figures, graphics and tables should be embedded in the text file or sent in separate files, preferably the former if possible.

Tables

Tables should have titles and sufficient experimental detail to be understandable without reference to the text. Number tables consecutively in the order of their first citation in the text (i.e. Tab. 1, Tab. 2, Tab. 3 etc.). Abbreviations must be defined in footnotes. Identify statistical measures of variations, such as standard deviation and standard error of the mean. Identify statistical significance by superscripts in front of the probabilities (P), as in: *P>0.05, **P<0.01 vs A.

Figures

Figures should have titles and legends containing sufficient detail to make the figure easily understood. Each figure should provided a Figure number (i.e. Fig. 1, Fig. 2, Fig. 3 etc) and a short figure title. Although you will initially submit figures with the text, we will require submission of figures as separate TIFF or JGP files at publication-quality resolution for print if your paper is accepted. Numbers, letters, and symbols should be clear (not smaller than 2 mm) and must be consistent in whole paper. Photomicrographs should have internal scale markers. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Identify statistical measures of variations, such as standard deviation and standard error of the mean.

Discussion

Discussion should not recapitulate the results, but discuss their significance against the background of existing knowledge, and identify clearly those aspects that are novel. The final paragraph should highlight the main conclusion(s), and provide some indication of the direction future research should take.

References

Authors should check the accuracy of all reference citations. Only articles and abstracts that have been published or are in press may be cited. References should be numbered consecutively and indicated by numbers in square brackets on the superscript in the text. The names of journals should be abbreviated according to "List of Journals Indexed" in Index Medicus. If there are more than 6 authors, the first six authors should be quoted followed by et al.

     Example: Journal artcicle